Veit JGS, De Glas V, Balau B, Liu H, et al. Characterization of CYP26B1-Selective Inhibitor, DX314, as a Potential Therapeutic for Keratinization Disorders. J Invest Dermatol 2021;141:72-83.
PMID: 32505549